Open AccessThe effects of virtual reality on functional capacity at different stages of Parkison’s disease
Author(s) -
Yuri Sena Melo,
Wesley Anderson de Souza Miranda,
João Lucas de Morais Bezerra,
Thaís Bel de Oliveira Teixeira
Publication year - 2021
Language(s) - English
Resource type - Conference proceedings
DOI - 10.5327/1516-3180.466
Subject(s) - virtual reality , disease , physical medicine and rehabilitation , rehabilitation , parkinson's disease , perception , inclusion (mineral) , medline , gait , physical therapy , medicine , psychology , computer science , artificial intelligence , neuroscience , pathology , social psychology , political science , law
the use of virtual reality in Parkinson’s disease is a very effective therapy, as it promotes important actions for the knowledge of the motor, stimulating neuroplasticity, through visual feedback. Study design: This is a systematic review of the literature. Objective: The objective of this study was to analyze the use of reality in the rehabilitation of functional capacity in the different stages of Parkinson’s disease. Methods: this is a systematic review, carried out from January to August 2017, by means of electronic search in the databases: Pubmed, Scielo, Lilacs, Science Direct and Medline. The descriptors used were: virtual, video game, Parkinson’s, physiotherapy and rehabilitation and all the words in English. They were defined as inclusion criteria for studies that used virtual reality as treatment for patients with Parkinson’s, classifying patients in stages (I, II, III, IV and V) according to the Hoehn & Yahr scale. Literature review articles, description of virtual reality without showing the sample of statistical results and case study were excluded. Results: 7 articles were selected. After analyzing them, it was possible to observe that patients in the early stages showed improvement in perception, gait and balance. However, patients who were in other more advanced stages of the disease only improved their perception. Conclusion: patients in the early stages of clinical Parkinson’s disease have satisfactory results when compared to the advanced stages.